Skip to main content
Premium Trial:

Request an Annual Quote

Acquisitions Drive 37-Percent Q1 Revenue Increase for Nanogen

NEW YORK, May 12 (GenomeWeb News) - Nanogen yesterday reported a 37-percent increase in first-quarter revenues, but a boost in operating expenses led to a 46-percent increase in net loss.


Nanogen's revenues for the quarter ended March 31 rose to $4.4 million from $3.2 million in the same period in 2005. Product revenues nearly doubled to $2.1 million from $1.2 million in the prior-year period, while revenues from license fees rose slightly to $1.8 million from $1.7 million in the first quarter of 2005.


Nanogen attributed the increase in product revenues to its recent acquisitions. The company acquired Spectral Diagnostic's cardiac test business in February, and closed its acquisition of Amplimedical on May 1.

Nanogen's net loss widened to $12 million, or $.21 per share, compared to $8.3 million, or $.17 per share in the same period of 2005.


The company said that its operating expenses included $1.4 million of non-cash accounting expense for share-based compensation, compared to $300,000 in share-based compensation in the prior-year period. In addition, the company recorded expenses related to its investment in Jurilab, which were not included in last year's results.


"Excluding these two items, expenses rose modestly to include the costs associated with the acquired Spectral operations," said Robert Saltmarsh, Nanogen's CFO, in a statement.


R&D spending rose to $6.3 million in the first quarter of 2006 from $4.9 million in the prior-yar period.


As of March 31, the company held $12.3 million in cash and cash equivalents. The company's cash position including short-term investments was $32.4 million.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.